Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II

Tao Ma; Raymond Chuen Chung Chang; Shannon L. Macauley

doi:10.3389/fnagi.2023.1150101

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II

Tao Ma, Raymond Chuen Chung Chang, Shannon L. Macauley

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Article number	1150101
Journal	Frontiers in Aging Neuroscience
Volume	15
DOIs	https://doi.org/10.3389/fnagi.2023.1150101
State	Published - Feb 3 2023

Bibliographical note

Funding Information:
This work was supported by National Institutes of Health grants R01 AG055581, R01 AG056622, and R01 AG073823 (TM).

Funding

This work was supported by National Institutes of Health grants R01 AG055581, R01 AG056622, and R01 AG073823 (TM).

Funders	Funder number
National Institutes of Health (NIH)	R01 AG056622, R01 AG073823, R01 AG055581

Keywords

Alzheimer's disease
MCI
aging
biomarker
brain imaging
cognitive impairment
metabolism

ASJC Scopus subject areas

Aging
Cognitive Neuroscience

Access to Document

10.3389/fnagi.2023.1150101

Cite this

@article{fb5deb1c98994e4fbb20cb2d454f86b1,

title = "Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II",

keywords = "Alzheimer's disease, MCI, aging, biomarker, brain imaging, cognitive impairment, metabolism",

author = "Tao Ma and Chang, \{Raymond Chuen Chung\} and Macauley, \{Shannon L.\}",

note = "Funding Information: This work was supported by National Institutes of Health grants R01 AG055581, R01 AG056622, and R01 AG073823 (TM). ",

year = "2023",

month = feb,

day = "3",

doi = "10.3389/fnagi.2023.1150101",

language = "English",

volume = "15",

}

TY - JOUR

T1 - Editorial

T2 - Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II

AU - Ma, Tao

AU - Chang, Raymond Chuen Chung

AU - Macauley, Shannon L.

N1 - Funding Information: This work was supported by National Institutes of Health grants R01 AG055581, R01 AG056622, and R01 AG073823 (TM).

PY - 2023/2/3

Y1 - 2023/2/3

KW - Alzheimer's disease

KW - MCI

KW - aging

KW - biomarker

KW - brain imaging

KW - cognitive impairment

KW - metabolism

UR - http://www.scopus.com/inward/record.url?scp=85148505192&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85148505192&partnerID=8YFLogxK

U2 - 10.3389/fnagi.2023.1150101

DO - 10.3389/fnagi.2023.1150101

M3 - Editorial

AN - SCOPUS:85148505192

SN - 1663-4365

VL - 15

JO - Frontiers in Aging Neuroscience

JF - Frontiers in Aging Neuroscience

M1 - 1150101

ER -

Editorial: Metabolic signaling dysregulation and cognitive impairments in aging and Alzheimer's disease, volume II

Bibliographical note

Funding

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this